SARS-CoV, MERS-CoV e SARS-CoV-2: uma revisão narrativa dos principais Coronavírus do século / SARS-CoV, MERS-CoV e SARS-CoV-2: a narrative review of the main Coronaviruses of the century

Layse Costa de Souza, Tayná Oliveira da Silva, Amanda Rebeca da Silva Pinheiro, Fabíola da Silva dos Santos

Abstract


SARS-CoV e MERS-CoV, vírus da família Coronaviridae, já foram responsáveis por epidemias passadas, no entanto apesar de similares, a magnitude da pandemia ocasionada pelo SARS-CoV-2 está além do já observado. Mesmo que pertençam à mesma família e causem sintomas parecidos, a COVID-19, doença ocasionada pelo SARS-CoV-2, possui diversas particularidades que não são observadas nas outras síndromes respiratórias. Apesar de possui a menor taxa de letalidade, os sintomas desenvolvidos pela COVID-19 podem se tornar persistentes e afetar a qualidade de vida, deixando sequelas significativas. Além disso, sintomas incomuns encontrados em pacientes vítimas da doença causada pelo SARS-CoV-2 ainda estão em constante observação. A grande capacidade de transmissão e a gravidade da doença são fatores que impulsionaram a ciência a trabalhar, em tempo recorde, visando um mesmo objetivo: entender o vírus para controlar a sua disseminação.


Keywords


Coronaviridae, Infecções Respiratórias, Pandemia.

References


ALSAAD, K. O.; HAJEER, A. H.; AL BALWI, M.; AL MOAIQUEL, M.; OUDAH, N.; AL AJLAN, A.; … & ARABI, Y. M. Histopathology of Middle East respiratory syndrome coronovirus (MERS‐CoV) infection–clinicopathological and ultrastructural study. Histopathology, v. 72, n. 3, p. 516-524, 2018.

CARFÌ, A.; BERNABEI, R.; LANDI, F. Persistent symptoms in patients after acute COVID-19. Jama, v. 324, n. 6, p. 603-605, 2020.

CHANNAPPANAVAR, R.; ZHAO, J.; PERLMAN, S. T cell-mediated immune response to respiratory coronaviruses. Immunologic research, v. 59, n. 1-3, p. 118-128, 2014.

CHRISTIAN, M. D.; MC DONALD, L. C.; MARTINEZ, K. F.; OFNER, M.; WONG, T.; … & SARS INVESTIGATION TEAM.Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerging infectious diseases, v. 10, n. 2, p. 287, 2004.

CHU, H.; ZHOU, J.; WONG, B. H. Y.; LI, C.; CHENG, Z. S.; LIN, X.; … & YUEN, K. Y. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology, v. 454, p. 197-205, 2014.

CORUM, J.; GRADY, D.; WEE, S. L.; ZIMMER, C. Coronavirus vaccine tracker. The New York Times, v. 5, 2020.

COTTEN, M.; WATSON, S. J.; KELLAM, P.; AL-RABEEAH, A. A.; MAKHDOOM, H. Q.; ASSIRI, A.; … & MEMISH, Z. A. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. The Lancet, v. 382, n. 9909, p. 1993-2002, 2013.

CRUNFLI, F.; CARREGARI, V. C.; VERAS, F. P.; VENDRAMINI, P.; H.; VALENÇA, A. G. F.; ANTUNES, A. S. L. M.; ... & MARTINS-DE-SOUZA, D. SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability. MedRxiv, 2020.

CUI, J.; LI, F.; SHI, Z. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, v. 17, n. 3, p. 181-192, 2019.

DAVANZO, G. G.; CODO, A. C.; BRUNETTI, N. S.; BOLDRINI, V. O.; KNITTEL, T. L.; MONTERIO, L. B.; … & FARIAS, A. S. SARS-CoV-2 Uses CD4 to Infect T Helper Lymphocytes. Medrxiv. Set. 2020. Disponível em:< https://www.medrxiv.org/>. Acesso em: 26 out. 2020.

DE BENEDICTIS, P.; MARCIANO, S.; SCARAVELLI, D.; PRIORI, P.; ZECCHIN, B.; CAPUA, I.; ... & CATTOLI, G. Alpha and lineage C betaCoV infections in Italian bats. Virus genes, v. 48, n. 2, p. 366-371, 2014.

DE GROOT, R. J.; BAKER, S. C.; BARIC, R. S.; BROWN, C. S.; DROSTEN, C.; ENJUANES, L.; … & ZIEBUHR, J. Commentary: Middle east respiratory syndrome coronavirus (mers-cov): announcement of the coronavirus study group. Journal of virology, v. 87, n. 14, p. 7790-7792, 2013.

DE JESUS, J. G.; SACCHI, C.; CLARO, I.; SALLES, F.; MANULLI, E.; SILVA, D.; ... & FARIA, N. R. First cases of coronavirus disease (COVID-19) in Brazil, South America (2 genomes, 3rd March 2020). Genome reports. Fev. 2020. Disponível em: < https://virological.org/t/first-cases-of-coronavirus-disease-covid-19-in-brazil-south-america-2-genomes-3rd-march-2020/409>. Acesso em: 14 out. 2020.

DING, Y.; ZHANG, Q.; HUANG, Z.; CHE, X.; HOU, J.; … & JIANG, S. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, v. 203, n. 2, p. 622-630, 2004.

DONNELLY, C. A.; MALIK. M. R.; ELKHOLY. A.; CAUCHEMEZ S.; VAN KERKHOVE, M. D. Worldwide reduction in MERS cases and deaths since 2016. Emerg Infect Dis. 2019.

DUARTE, G.; QUINTANA, S. M. Infecção pelo Coronavírus SARS-CoV-2 em Obstetrícia: Enfrentando o desconhecido. Febras. Mar. 2020. Disponível em:< https://www.febrasgo.org.br/>. Acesso em: 11 abr. 2020.

DUDAS, Gytis; RAMBAUT, Andrew. MERS-CoV recombination: implications about the reservoir and potential for adaptation. Virus evolution, v. 2, n. 1, 2016.

FIOCRUZ. Impactos sociais, econômicos, culturais e políticos da pandemia. Disponível em:<https://portal.fiocruz.br/impactos-sociais-economicos>. Acesso em: 09 dez. 2020.

GE, X.; LI, J. L.; YANG, X. L.; CHMURA, A. A.; ZHU, G.; EPSTEIN, J. H.; … & SHI, Z. L. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature, v. 503, n. 7477, p. 535-538, 2013.

GRIFONI, A.; WEISKOPF, D.; RAMIREZ, S. I.; MATEUS, J.; DAN, J. M.; MODERBACHER, C. R.; ... & SETTE, A. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell, v. 181, jun. 2020. Disponível em:https:. Acesso em: 25 jul. 2020.

GUAN, Y.; ZHENG, B. J.; HE, Y. Q.; LIU, X. L.; ZHUANG, Z. X.; CHEUNG, C. L.; … & POON, L. L. M. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science, v. 302, n. 5643, p. 276-278, 2003.

HE, Y.; ZHOU, Y.; SIDDIQUI, P.; JIANG, S.Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry. Biochemical and biophysical research communications, v. 325, n. 2, p. 445-452, 2004.

HERNANDEZ, C.; BRUCKNER, A. L. Focus on “COVID toes”. JAMA dermatology, v. 156, n. 9, p. 1003-1003, 2020.

HO, K. Y.; SINGH, K. S.; HABIB, A. G.; ONG, B. K.; LIM, T. K.; OOI, E. E.; …& TAMBYAH, P. A. Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore. The Journal of infectious diseases, v. 189, n. 4, p. 642-647, 2004.

HSU, L. Y.; CHIA, P. Y.; LIM, J. F. The Novel Coronavirus (SARS-CoV-2) Pandemic. Annals, Academy of Medicine, v. 49, n. 3, mar. 2020. Disponível em:<https://www.annals.edu.sg>. Acesso em: 09 dez. 2020.

ITHETE, N. L.; STOFFBERG, S.; CORMAN, V. M.; COTTONTAIL, V. M.; RICHARDS, L. R.; SCHEMAN, M. C.; … & PREISER, W. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerging infectious diseases, v. 19, n. 10, p. 1697, 2013

JOGALEKAR, M. P.; VEERABATHINI, A.; GANGADARAN, P.; Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions. Experimental Biology and Medicine, v. 245, n. 11, abr. 2020. Disponível em:< https://journals.sagepub.com/>. Acesso em: 22 jul. 2020.

LANA, R. M.; COELHO, F. C.; GOMES, M. F. D. C.; CRUZ, O. G.; BASTOS, L. S.; VILLELA, D. A. M.; CODEÇO, C. T. Emergência do novo coronavírus (SARS-CoV-2) e o papel de uma vigilância nacional em saúde oportuna e efetiva. Cad. Saúde Pública, v. 36, n. 3, fev. 2020. Disponível em:. Acesso em: 23 jul. 2020.

LONG, Q. X.; TANG, X. J.; SHI, Q. L.; LI, Q.; DENG, H, J.; YUAN, J.; … & HUANG, A. L. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Medicine, jun. 2020. Disponível em:. Acesso em: 26 jul. 2020.

LU, G.; HU, Y.; WANG, Q.; QI, J.; GAO, F.; LI, Y.; ... & GAO, G. F. Base molecular da ligação entre o novo coronavírus humano MERS-CoV e seu receptor CD26. Nature 500, 227–231 (2013).

MACHADO, A. Últimas notícias sobre o coronavírus no Brasil e no mundo. El País, São Paulo, 11 abr. 2020. Disponível em:. Acesso em: 11 abr. 2020.

MACKAY, I. M.; ARDEN, K. E. MERS coronavirus: diagnostics, epidemiology and transmission. Virology journal, v. 12, n. 1, p. 1-21, 2015.

MAHASE, E. Covid-19: UK approves Oxford vaccine as cases of new variant surge. 2020.

MARRA, M. A.; JONES, S.; J.; ASTELL, C. R.; HOLT, R. A.; BROOKS-WILSON, A.; BUTTERFIELS, Y. S.; … & ROPER, R. L. The genome sequence of the SARS-associated coronavirus. Science, v. 300, n. 5624, p. 1399-1404, 2003.

MINISTÉRIO DA SAÚDE. MS. Informe Técnico - MERS-CoV (Novo Coronavírus). Jun. 2014. Disponível em: < http://portalarquivos.saude.gov.br/images/pdf/2014/junho/10/Informe-T--cnico-para-Profissionais-da-Sa--de-sobre-MERS-CoV-09-06-2014-ok.pdf>. Acesso em: 10 jun. 2020.

MUHAMMAD, A. S. et al. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research, v. 24, mar. 2020. Disponível em:. Acesso em: 22 jul. 2020.

MÜLLER, N. L.; OOI, G. C.; KHONG, P. L.; NICOLAOU, S. Severe acute respiratory syndrome: radiographic and CT findings. American Journal of Roentgenology, v. 181, n. 1, p. 3-8, 2003.

MUSTAFA, M. W. M. Audiological profile of asymptomatic Covid-19 PCR-positive cases. Am J Otolaryngol, v. 41, abr. 2020. Disponível em:< https://www.ncbi.nlm.nih.gov>. Acesso em: 20 dez. 2020.

NICHOLLS, J. M.; POON, L. L.; LEE, K. C.; NG, W. F.; LAI, S. T.; LEUNG, C. Y.; … & PEIRIS, J. M. Lung pathology of fatal severe acute respiratory syndrome. The Lancet, v. 361, n. 9371, p. 1773-1778, 2003.

OMMEH, S.; ZHANG, W.; ZOHAIB, A.; CHEN, J.; ZHANG, H.; HU, B.; … & SHI, Z. L. Genetic evidence of Middle East respiratory syndrome coronavirus (MERS-Cov) and widespread seroprevalence among camels in Kenya. Virologica Sinica, v. 33, n. 6, p. 484-492, 2018.

PEIRIS, J. S. M.; LAI, S. T.; POON, L. L. M.; GUAN, Y.; YAM, L. Y. C.; LIM, W.; … & SARS STUDY GROUP. Coronavirus as a possible cause of severe acute respiratory syndrome. The Lancet, v. 361, n. 9366, p. 1319-1325, 2003.

PEIRIS, J. S. M.; CHU, C. M.; CHENG, V.C. C.; CHAN, K. S.; HUNG, I. F. N.; POON, L. L.; … & HKU/UCH SARS STUDY GROUP. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. The Lancet, v. 361, n. 9371, p. 1767-1772, 2003.

PENG, H.; YANG, L. T.; WANG, L. Y.; LI, J.; HUANG, J.; LU, Z. Q.; … & WU, C. Y. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology, v. 351, n. 2, p. 466-475, 2006.

PERLMAN, S. Another Decade, Another Coronavirus. The New England Journal of Medicine, v. 382, n. 8. Fev. 2020. Disponível em:. Acesso em: 30 mar. 2020.

PETERSEN, E.; KOOPMANS, M.; GO, U.; HAMER, D. H.; PETROSILLO, N.; CASTELLI, F.; … & SIMONSEN, L. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. The Lancet, v. 20, ago. 2020. Disponível em:< https://www.sciencedirect.com>. Acesso em: 09 dez. 2020.

PETROSILLO, N.; VICECONTE, G.; ERGONUL, O.; IPPOLITO, G.; PETERSEN, E. COVID-19, SARS and MERS: are they closely related?. Clinical Microbiology and Infection, 2020.

POUTANEN, S. M.; LOW, D. E.; HENRY, B.; FINKELSTEIN, S.; ROSE, D.; GREEN, K.; … & MCGEER, A. J. Identification of severe acute respiratory syndrome in Canada. New England Journal of Medicine, v. 348, n. 20, p. 1995-2005, 2003.

RAJ, V. S.; MOU, H.; SMITS, S. L.; DEKKERS, D. H.; MULLER, M. A.; DIJKMAN, R.; … & HAAGMANS, B. L. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature, v. 495, n. 7440, p. 251-254, 2013.

RIBAS, A. R.; FREITAS, M. N.; DONALISIO, M. R. Assessing the severity of COVID-19. Epidemiol. Serv. Saúde, v. 29, n. 2, abr. 2020. Disponível em:< https://www.scielosp.org/article/ress/2020.v29n2/e2020119/>. Acesso em: 09 dez. 2020.

ROBBIANI, D. F.; GAEBLER, C.; MUECKSCH, F.; LORENZI, J. C.; WANG, Z.; CHO, A.; … & NUSSENZWEIG, M. C. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature Medicine, jun. 2020. Disponível em:. Acesso em: 27 jul. 2020.

RUAN, Y.; WEI, C. L.; LING, A. E.; VEGA, V. B.; THOREAU, H. THOE, S. Y. S.; … & LIU, E. T. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. The Lancet, v. 361, n. 9371, p. 1779-1785, 2003.

SANTOS, N. S. O; ROMANOS, M. T. V; WIGG, D. M. Virologia Humana. 3. ed. Rio de Janeiro: Guanabara Koogan, 2015. 1308 p.

SETO, W. H.; TSANG, D.; YUNG, R. W. H.; CHING, T. Y.; NG, T. K.; HO, M.; … & ADVISORS OF EXPERT SARS GROUP OS HOSPITAL AUTHORITY. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). The Lancet, v. 361, n. 9368, p. 1519-1520, 2003.

SHI, S.; QIN, M.; SHEN, B.; CAI, Y.; LIU, T.; YANG, F.; … & HUANG, C. . Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology, 2020.

SIMS, A. C.; BARIC, R. S.; YOUNT, B.; BURKETT, S. E.; COLLINS, P. L.; PICKLES, R. J. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. Journal of virology, v. 79, n. 24, p. 15511-15524, 2005.

SOCIEDADE BRASILEIRA DE DERMATOLOGIA (SBD). Coronavírus e COVID-19: cuidados de prevenção com a pele, cabelos e unhas. Disponível em:< https://www.sbd.org.br/>. Acesso em: 20 dez. 2020.

SOCIEDADE DE PEDIATRIA DO ESTADO DO RIO DE JANEIRO (SOPERJ). Covid –19 e comprometimento ocular. Disponível em:. Acesso em: 20 dez. 2020.

THOMPSON, Stuart A. How long will a vaccine really take. New York Times, v. 30, 2020.

TOSCANO, G.; PALMERINI, F.; RAVAGLIA, S.; RUIZ, L.; INVERNIZZI, P.; CUZZONI, M. G.; ... & MICIELI, G. Guillain–Barré syndrome associated with SARS-CoV-2. New England Journal of Medicine, 2020.

VAN BOHEEMEN, S.; DE GRAAF, M.; LAUBER, C.; BESTEBROER, T. M.; RAJ, V. S.; ZAKI, A. M.; … & FOUCHIER, R. A. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio, v. 3, n. 6, 2012.

WACHARAPLUESADEE, S.; SINTUNAWA, C.; KAEWPOM, T.; KHONGOMNAN, K. OLIVAL, K. J.; EPSTEIN, J. H; ... & HEMACHUDHA, T. Group C betacoronavirus in bat guano fertilizer, Thailand. Emerging infectious diseases, v. 19, n. 8, p. 1349, 2013.

WANG, Y.; LIU, D.; SHI, W.; LU, R.; WANG, W.; ZHAO, Y.; … & TAN, W. Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis. MBio, v. 6, n. 5, 2015.

WORLD HEALTH ORGANIZATION, WHO. WHO issues a global alert about cases of atypical pneumonia. Mar. 2003. Disponível em: < https://www.who.int/mediacentre/news/releases/2003/pr22/en/>. Acesso em: 10 jun 2020.

WORLD HEALTH ORGANIZATION. WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS). Updated recommendations October 2004. Disponível em: https://www.who.int/csr/resources/publications/WHO_CDS_CSR_ARO_2004_1.pdf. Acesso em: 13 jun. 2020.

XIA, S.; LIU, Q.; WANG, Q.; SUN, Z.; SU, S.; DU, L.; … & JIANG, S. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus research, v. 194, p. 200-210, 2014.

XIONG, S.; WANG, Y. F.; ZHANG, M. Y.; LIU, X. J.; ZHANG, C. H.; LIU, S. S.; … & FAN, J. L. Immunogenicity of SARS inactivated vaccine in BALB/c mice. Immunology letters, v. 95, n. 2, p. 139-143, 2004.

YANG, R.; LAN, J.; HUANG, B.; RUHAN, A.; LU, M.; WANG, W.; … &TAN, W. Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections. EBioMedicin, v. 58, jun. 2020. Disponível em:< https://www.sciencedirect.com>. Acesso em: 25 jul. 2020.

YEE, J.; UNGER, L.; ZADRAVECZ, F.; CARIELLO, P.; SEIBERT, A.; JOHNSON, M. A.; FULLER, M. J. Novel coronavirus 2019 (COVID-19): Emergence and implications for emergency care. Jacep Open, v. 1, n. 7. Fev. 2020. Disponível em:< https://onlinelibrary.wiley.com/doi/pdf/10.1002/emp2.12034>. Acesso em: 29 mar. 2020.

ZAKI, A. M.; VAN BOHEEMEN, S.; BESTEBROER, T. M.; OSTERHAUS, A. D.; FOUCHIER, R. A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New England Journal of Medicine, v. 367, n. 19, p. 1814-1820, 2012.

ZHANG, Y.; LI, J.; ZHAN, Y.; WU, L.; YU, X.; ZHANG, W.; … & LOU, J. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infection and immunity, v. 72, n. 8, p. 4410-4415, 2004.

ZHONG, N. S.; ZHENG, B. J.; LI, Y. M.; POON, L. L. M.; XIE, Z. H.; CHAN, K. H.; … & GUAN, Y. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. The Lancet, v. 362, n. 9393, p. 1353-1358, 2003.

ZHU, F.; LI, Y. H.; GUAN, X. H.; HOU, L. H.; WANG, W. J.; LI, J, X.; … & CHEN, W. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. The Lancet, v. 395, jun. 2020. Disponível em:< www.thelancet.com>. Acesso em: 27 jul. 2020




DOI: https://doi.org/10.34119/bjhrv4n1-120

Refbacks

  • There are currently no refbacks.